Further supporting the SOX9 association with ER− tumors, we found that SOX9-high (Z score ≥ 2) breast cancer had significantly decreased ESR1 at both the RNA and protein levels (Figure S2E; Cerami et al., 2012; Gao et al., 2013). This evidence concerns the gene SOX9 and breast cancer.